Matthew Finneran to Cost-Benefit Analysis
This is a "connection" page, showing publications Matthew Finneran has written about Cost-Benefit Analysis.
Connection Strength
0.418
-
The Accuracy and Cost-Effectiveness of Selective Fetal Echocardiography for the Diagnosis of Congenital Heart Disease in Patients with Pregestational Diabetes Stratified by Hemoglobin A1c. Am J Perinatol. 2019 10; 36(12):1216-1222.
Score: 0.147
-
Cost Analysis of Azithromycin versus Erythromycin in Pregnancies Complicated by Preterm Premature Rupture of Membranes. Am J Perinatol. 2019 01; 36(1):105-110.
Score: 0.141
-
Comparison of Azithromycin versus Erythromycin for Prolongation of Latency in Pregnancies Complicated by Preterm Premature Rupture of Membranes. Am J Perinatol. 2017 09; 34(11):1102-1107.
Score: 0.130